Very preterm neonates who later develop bronchopulmonary dysplasia (BPD) exhibit persistently low broncho-alveolar SP-D, and recombinant human SP-D attenuates hyperoxic lung injury in pre-clinical models [12]. This evidence concerns the gene SFTPD and bronchopulmonary dysplasia.